Researchers have discovered that methotrexate (MTX) therapy may substantially diminish vaccine-induced CD4 T cell activation ...

The following is a summary of “Similar humoral responses but distinct CD4+ T cell transcriptomic profiles in older adults ...

A new study identifies potential immune profile differences in patients with chronic lymphocytic leukemia (CLL) that may lead ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...

To make sure the causal findings were robust, a sensitivity analysis was done. Results: In both discovery and validation GWAS, a critical inverse correlation between CD4+ T cells and BC risk was found ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

To study T cell behavior, we developed a 3D model using intestinal organoids, also known as mini-guts. This model allowed us to observe how different types of intestinal damage affect intestinal ...

New non-human primate data show highly selective in vivo delivery of mRNA to T cells with a cell-targeted lipid nanoparticle ...

Gilead Sciences (GILD) and Merck (MRK) announced new results from a Phase 2 clinical study evaluating the investigational ...

A second CAR T-cell expansion started day on 39 but consisted of multiple CAR+ populations. Two CAR+ populations were characterized by CD4+ or CD8+ expression, and one population was negative for ...